Medical Animation Market by Type (3D, 2D, 4D), Therapeutic Area (Oncology, Cosmeceutical/Plastic Surgery), Application (Drug MoA, Patient Education), End User (Medical Device Manufacturers, Hospitals/ Clinics) - Forecast to 2021
The medical animation market is poised to reach USD 301.3 million by 2021 from USD 117.3 million in 2016, growing at a CAGR of 20.8% during the forecast period of 2016 to 2021.
Medical animation is an educational video or movie created using 3D motion graphics to explain the mechanism of action (MoA) of a medical device, biomedical technology, pharmaceutical drug, or an anatomical or biological process. Animations are used in the medical and pharmaceutical sectors for educational purposes, demonstrations, simulation of surgeries, and analysis and comparative evaluation of treatment.
The 3D animation segment is expected to account for the largest share of the medical animation market, by type, in 2016. 3D animation provides viewers a greater sense of perspective, and enables clear understanding of the key concepts in a forensic case; this is contributing to the large share of this segment. The drug mechanism of action (MoA) and approvals segment is expected to account for the largest share of the medical animation market, by application, in 2016. The rising adoption of medical animation by pharmaceutical companies for showcasing the MoA of drugs as well as for the marketing, promotions, and approvals of products is driving growth in this market segment. The oncology segment is expected to account for the largest share of the global medical animation market, by therapeutic area, in 2016. This is attributed to the increasing awareness amongst healthcare professionals on various diseases, injuries, and defects; and rising adoption among academic institutes to explain and provide instructions to students on physiotherapy and pre- and post-orthopedic procedures. The life science companies segment is estimated to account for the largest share of the medical animation market, by end user, in 2016. Life sciences companies mainly use medical animation as a marketing tool to promote new drugs and product offerings.
North America is expected to account for the largest share of the global medical animation market in 2016, followed by Europe, Asia-Pacific, and the Rest of the World (RoW). The large share of the North American region can be attributed to the presence of major pharmaceutical companies, increased healthcare spending, presence of top market players, increasing number of surgeries in the U.S., and growing medical devices industry in Canada. The Asia-Pacific region is expected to witness the highest growth rate in the forecast period, mainly due to the growing pharmaceutical industry, growing number of medical institutes in India, lucrative medical devices industry in China, and entry of local players and low cost of medical animation in India.
The medical animation market witnesses high competitive intensity, as there are several big and many small firms with similar product offerings. These companies adopt various strategies (agreements, partnerships, joint ventures, collaborations, expansions, new product launches, and acquisition) to increase their market shares and establish a stronger foothold in the global market.
Prominent players in the global medical animation market include Infuse Medical (U.S.), Hybrid Medical Animation, Inc. (U.S.), Ghost Productions, Inc. (U.S.), Scientific Animations, Inc. (U.S.), INVIVO Communications, Inc. (Canada), Random42 Scientific Communication (U.K.), Radius Digital Science (U.S.), Nucleus Medical Media, Inc. (U.S.), AXS Studio, Inc. (Canada), Visible Body (U.S.), Elara Systems, Inc. (U.S.), Animated Biomedical Productions (Australia), XVIVO Scientific Animation (U.S.), Blausen Medical Communications, Inc. (U.S.), Trinsic Medical Animation, LLC. (U.S.), Viscira (U.S.), Understand.com (U.S.), and Medmovie, Inc. (U.S.).
Reasons to Buy the Report:
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help them garner a greater market share. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares. The report provides insights on the following pointers:
Medical animation is an educational video or movie created using 3D motion graphics to explain the mechanism of action (MoA) of a medical device, biomedical technology, pharmaceutical drug, or an anatomical or biological process. Animations are used in the medical and pharmaceutical sectors for educational purposes, demonstrations, simulation of surgeries, and analysis and comparative evaluation of treatment.
The 3D animation segment is expected to account for the largest share of the medical animation market, by type, in 2016. 3D animation provides viewers a greater sense of perspective, and enables clear understanding of the key concepts in a forensic case; this is contributing to the large share of this segment. The drug mechanism of action (MoA) and approvals segment is expected to account for the largest share of the medical animation market, by application, in 2016. The rising adoption of medical animation by pharmaceutical companies for showcasing the MoA of drugs as well as for the marketing, promotions, and approvals of products is driving growth in this market segment. The oncology segment is expected to account for the largest share of the global medical animation market, by therapeutic area, in 2016. This is attributed to the increasing awareness amongst healthcare professionals on various diseases, injuries, and defects; and rising adoption among academic institutes to explain and provide instructions to students on physiotherapy and pre- and post-orthopedic procedures. The life science companies segment is estimated to account for the largest share of the medical animation market, by end user, in 2016. Life sciences companies mainly use medical animation as a marketing tool to promote new drugs and product offerings.
North America is expected to account for the largest share of the global medical animation market in 2016, followed by Europe, Asia-Pacific, and the Rest of the World (RoW). The large share of the North American region can be attributed to the presence of major pharmaceutical companies, increased healthcare spending, presence of top market players, increasing number of surgeries in the U.S., and growing medical devices industry in Canada. The Asia-Pacific region is expected to witness the highest growth rate in the forecast period, mainly due to the growing pharmaceutical industry, growing number of medical institutes in India, lucrative medical devices industry in China, and entry of local players and low cost of medical animation in India.
The medical animation market witnesses high competitive intensity, as there are several big and many small firms with similar product offerings. These companies adopt various strategies (agreements, partnerships, joint ventures, collaborations, expansions, new product launches, and acquisition) to increase their market shares and establish a stronger foothold in the global market.
Prominent players in the global medical animation market include Infuse Medical (U.S.), Hybrid Medical Animation, Inc. (U.S.), Ghost Productions, Inc. (U.S.), Scientific Animations, Inc. (U.S.), INVIVO Communications, Inc. (Canada), Random42 Scientific Communication (U.K.), Radius Digital Science (U.S.), Nucleus Medical Media, Inc. (U.S.), AXS Studio, Inc. (Canada), Visible Body (U.S.), Elara Systems, Inc. (U.S.), Animated Biomedical Productions (Australia), XVIVO Scientific Animation (U.S.), Blausen Medical Communications, Inc. (U.S.), Trinsic Medical Animation, LLC. (U.S.), Viscira (U.S.), Understand.com (U.S.), and Medmovie, Inc. (U.S.).
Reasons to Buy the Report:
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help them garner a greater market share. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares. The report provides insights on the following pointers:
- Market Penetration: Comprehensive information on the product portfolios of the top players in the medical animation market. The report analyzes the market based on type, application, therapeutic area, and end user
- Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and new product launches in the medical animation market
- Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various medical animations across regions
- Market Diversification: Exhaustive information about new products, untapped regions, recent developments, and investments in the medical animation market
- Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the medical animation market
1 INTRODUCTION
1.1 OBJECTIVES OF STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH METHODOLOGY STEPS
2.2 SECONDARY AND PRIMARY RESEARCH METHODOLOGY
2.2.1 SECONDARY RESEARCH
2.2.1.1 Key data from secondary sources
2.2.2 PRIMARY RESEARCH
2.3 KEY INDUSTRY INSIGHTS
2.4 KEY DATA FROM PRIMARY SOURCES
2.5 KEY INSIGHTS FROM PRIMARY SOURCES
2.6 MARKET SIZE ESTIMATION METHODOLOGY
2.7 MARKET FORECAST METHODOLOGY
2.8 MARKET DATA VALIDATION AND TRIANGULATION
2.9 ASSUMPTIONS FOR THE STUDY
3 EXECUTIVE SUMMARY
3.1 INTRODUCTION
3.2 CURRENT AND FUTURE SCENARIO
3.3 KEY GROWTH STRATEGIES
4 PREMIUM INSIGHTS
4.1 MEDICAL ANIMATION: MARKET OVERVIEW
4.2 GLOBAL MEDICAL ANIMATION MARKET, BY APPLICATION
4.3 GEOGRAPHIC ANALYSIS: MEDICAL ANIMATION MARKET, BY TYPE
4.4 MEDICAL ANIMATION MARKET, BY END USER
4.5 GEOGRAPHIC SNAPSHOT OF THE MEDICAL ANIMATION MARKET (2016)
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET SEGMENTATION
5.3 MARKET DYNAMICS
5.3.1 DRIVERS
5.3.1.1 Rising adoption of medical animation by life science & medical device companies
5.3.1.2 Entry of start-ups in the medical animation market
5.3.1.3 Growing pharmaceutical/biopharmaceutical and medical devices industry
5.3.1.4 Increasing penetration of smartphones, tablets, and other mobile platforms
5.3.1.5 Rising geriatric population and growing number of surgeries globally
5.3.2 RESTRAINT
5.3.2.1 High cost of medical animation services
5.3.3 OPPORTUNITIES
5.3.3.1 Low health literacy
5.3.3.2 Emerging economies
5.3.4 CHALLENGE
5.3.4.1 Dearth of certified medical animators
6 MEDICAL ANIMATION MARKET, BY TYPE
6.1 INTRODUCTION
6.2 3D ANIMATION
6.3 2D ANIMATION
6.4 REAL TIME IMAGING (4D ANIMATION)
6.5 FLASH ANIMATION
7 MEDICAL ANIMATION MARKET, BY THERAPEUTIC AREA
7.1 INTRODUCTION
7.2 ONCOLOGY
7.3 CARDIOLOGY
7.4 COSMECEUTICALS/PLASTIC SURGERY
7.5 DENTAL
7.6 OTHERS
8 MEDICAL ANIMATION MARKET, BY APPLICATION
8.1 INTRODUCTION
8.2 DRUG MECHANISM OF ACTION (MOA) AND APPROVAL
8.3 PATIENT EDUCATION
8.4 SURGICAL TRAINING AND PLANNING
8.5 CELLULAR AND MOLECULAR STUDIES
8.6 OTHER APPLICATIONS
9 MEDICAL ANIMATION MARKET, BY END USER
9.1 INTRODUCTION
9.2 LIFE SCIENCE COMPANIES
9.3 MEDICAL DEVICE MANUFACTURERS
9.4 HOSPITALS, SURGICAL CENTERS, AND CLINICS
9.5 ACADEMIC INSTITUTES
9.6 OTHER END USERS
10 GLOBAL MEDICAL ANIMATION MARKET, BY REGION
10.1 INTRODUCTION
10.2 NORTH AMERICA
10.3 U.S.
10.3.1 PRESENCE OF MAJOR PHARMACEUTICAL COMPANIES IN THE U.S.
10.3.2 PRESENCE OF TOP PLAYERS COUPLED WITH INCREASING COLLABORATIONS AND PARTNERSHIPS
10.3.3 ACADEMIC INSTITUTES TO BOOST THE MEDICAL ANIMATION MARKET IN THE U.S.
10.3.4 CONFERENCES & EVENTS THAT FACILITATE KNOWLEDGE EXCHANGE
10.3.5 INCREASING SURGERIES IN THE U.S.
10.3.6 INCREASING HEALTHCARE SPENDING
10.4 CANADA
10.4.1 GROWING MEDICAL DEVICES INDUSTRY
10.4.2 INCREASING USAGE OF MOBILE DEVICES IN CANADA
10.5 EUROPE
10.5.1 EU5
10.5.1.1 Increased investments in pharmaceutical development in the U.K.
10.5.1.2 Growing medical devices industry in Germany
10.5.1.3 Growing biotech and pharmaceutical industry in Italy
10.5.2 ROE
10.5.2.1 Denmark: a standout in life sciences
10.5.2.2 Upward trend in Russia’s pharmaceutical sector
10.6 ASIA-PACIFIC
10.6.1 HIGH GROWTH IN THE ASIAN PHARMACEUTICAL INDUSTRY
10.6.2 LUCRATIVE MEDICAL DEVICES INDUSTRY IN CHINA
10.6.3 GROWING NUMBER OF HOSPITALS IN ASIA
10.6.4 CONFERENCES & SYMPOSIA TO INCREASE AWARENESS
10.6.5 ENTRY OF LOCAL PLAYERS, LOW COST OF MEDICAL ANIMATION IN INDIA
10.6.6 EMERGENCE OF NEW MEDICAL INSTITUTES IN INDIA
10.7 REST OF THE WORLD (ROW)
10.7.1 FAVORABLE BUSINESS ENVIRONMENT FOR PHARMACEUTICAL AND BIOTECHNOLOGY INDUSTRIES IN SAUDI ARABIA, UAE
10.7.2 FAVORABLE ECOSYSTEM FOR MEDICAL ANIMATION IN BRAZIL
10.7.3 GOVERNMENT INITIATIVES TO ENHANCE HEALTHCARE SYSTEMS IN THE MIDDLE EAST
11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW
11.2 COMPETITIVE SITUATION AND TRENDS
11.2.1 INTRODUCTION
11.2.2 NEW PRODUCT LAUNCHES
11.2.3 MARKETING AND PROMOTIONS
11.2.4 AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS
11.2.5 EXPANSIONS
11.2.6 ACQUISITIONS
11.2.7 OTHER DEVELOPMENTS
11.3 GLOBAL MEDICAL ANIMATION MARKET: EMPIRICAL ASSESSMENT OF GROWTH STRATEGIES
11.3.1 ROUTE TO STRATEGIC GROWTH: ORGANIC AND INORGANIC GROWTH STRATEGIES
11.3.2 ORGANIC GROWTH STRATEGIES
11.3.3 INORGANIC GROWTH STRATEGIES
12 COMPANY PROFILES
(Overview, Financial*, Products & Services, Strategy, and Developments)
12.1 INFUSE MEDICAL
12.2 HYBRID MEDICAL ANIMATION, INC.
12.3 GHOST PRODUCTIONS, INC.
12.4 SCIENTIFIC ANIMATIONS, INC.
12.5 INVIVO COMMUNICATIONS, INC.
12.6 RANDOM42 SCIENTIFIC COMMUNICATION
12.7 RADIUS DIGITAL SCIENCE
12.8 NUCLEUS MEDICAL MEDIA
12.9 AXS STUDIO, INC.
12.10 VISIBLE BODY
12.11 ELARA SYSTEMS, INC.
12.12 ANIMATED BIOMEDICAL PRODUCTIONS
12.13 XVIVO SCIENTIFIC ANIMATION
12.14 BLAUSEN MEDICAL COMMUNICATIONS, INC.
12.15 UNDERSTAND.COM
12.16 TRINSIC ANIMATION, LLC.
12.17 VISCIRA
12.18 MEDMOVIE, INC.
*Details might not be captured in case of unlisted companies.
13 APPENDIX
13.1 DISCUSSION GUIDE
13.2 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
13.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.4 AVAILABLE CUSTOMIZATIONS
13.5 RELATED REPORTS
1.1 OBJECTIVES OF STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH METHODOLOGY STEPS
2.2 SECONDARY AND PRIMARY RESEARCH METHODOLOGY
2.2.1 SECONDARY RESEARCH
2.2.1.1 Key data from secondary sources
2.2.2 PRIMARY RESEARCH
2.3 KEY INDUSTRY INSIGHTS
2.4 KEY DATA FROM PRIMARY SOURCES
2.5 KEY INSIGHTS FROM PRIMARY SOURCES
2.6 MARKET SIZE ESTIMATION METHODOLOGY
2.7 MARKET FORECAST METHODOLOGY
2.8 MARKET DATA VALIDATION AND TRIANGULATION
2.9 ASSUMPTIONS FOR THE STUDY
3 EXECUTIVE SUMMARY
3.1 INTRODUCTION
3.2 CURRENT AND FUTURE SCENARIO
3.3 KEY GROWTH STRATEGIES
4 PREMIUM INSIGHTS
4.1 MEDICAL ANIMATION: MARKET OVERVIEW
4.2 GLOBAL MEDICAL ANIMATION MARKET, BY APPLICATION
4.3 GEOGRAPHIC ANALYSIS: MEDICAL ANIMATION MARKET, BY TYPE
4.4 MEDICAL ANIMATION MARKET, BY END USER
4.5 GEOGRAPHIC SNAPSHOT OF THE MEDICAL ANIMATION MARKET (2016)
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET SEGMENTATION
5.3 MARKET DYNAMICS
5.3.1 DRIVERS
5.3.1.1 Rising adoption of medical animation by life science & medical device companies
5.3.1.2 Entry of start-ups in the medical animation market
5.3.1.3 Growing pharmaceutical/biopharmaceutical and medical devices industry
5.3.1.4 Increasing penetration of smartphones, tablets, and other mobile platforms
5.3.1.5 Rising geriatric population and growing number of surgeries globally
5.3.2 RESTRAINT
5.3.2.1 High cost of medical animation services
5.3.3 OPPORTUNITIES
5.3.3.1 Low health literacy
5.3.3.2 Emerging economies
5.3.4 CHALLENGE
5.3.4.1 Dearth of certified medical animators
6 MEDICAL ANIMATION MARKET, BY TYPE
6.1 INTRODUCTION
6.2 3D ANIMATION
6.3 2D ANIMATION
6.4 REAL TIME IMAGING (4D ANIMATION)
6.5 FLASH ANIMATION
7 MEDICAL ANIMATION MARKET, BY THERAPEUTIC AREA
7.1 INTRODUCTION
7.2 ONCOLOGY
7.3 CARDIOLOGY
7.4 COSMECEUTICALS/PLASTIC SURGERY
7.5 DENTAL
7.6 OTHERS
8 MEDICAL ANIMATION MARKET, BY APPLICATION
8.1 INTRODUCTION
8.2 DRUG MECHANISM OF ACTION (MOA) AND APPROVAL
8.3 PATIENT EDUCATION
8.4 SURGICAL TRAINING AND PLANNING
8.5 CELLULAR AND MOLECULAR STUDIES
8.6 OTHER APPLICATIONS
9 MEDICAL ANIMATION MARKET, BY END USER
9.1 INTRODUCTION
9.2 LIFE SCIENCE COMPANIES
9.3 MEDICAL DEVICE MANUFACTURERS
9.4 HOSPITALS, SURGICAL CENTERS, AND CLINICS
9.5 ACADEMIC INSTITUTES
9.6 OTHER END USERS
10 GLOBAL MEDICAL ANIMATION MARKET, BY REGION
10.1 INTRODUCTION
10.2 NORTH AMERICA
10.3 U.S.
10.3.1 PRESENCE OF MAJOR PHARMACEUTICAL COMPANIES IN THE U.S.
10.3.2 PRESENCE OF TOP PLAYERS COUPLED WITH INCREASING COLLABORATIONS AND PARTNERSHIPS
10.3.3 ACADEMIC INSTITUTES TO BOOST THE MEDICAL ANIMATION MARKET IN THE U.S.
10.3.4 CONFERENCES & EVENTS THAT FACILITATE KNOWLEDGE EXCHANGE
10.3.5 INCREASING SURGERIES IN THE U.S.
10.3.6 INCREASING HEALTHCARE SPENDING
10.4 CANADA
10.4.1 GROWING MEDICAL DEVICES INDUSTRY
10.4.2 INCREASING USAGE OF MOBILE DEVICES IN CANADA
10.5 EUROPE
10.5.1 EU5
10.5.1.1 Increased investments in pharmaceutical development in the U.K.
10.5.1.2 Growing medical devices industry in Germany
10.5.1.3 Growing biotech and pharmaceutical industry in Italy
10.5.2 ROE
10.5.2.1 Denmark: a standout in life sciences
10.5.2.2 Upward trend in Russia’s pharmaceutical sector
10.6 ASIA-PACIFIC
10.6.1 HIGH GROWTH IN THE ASIAN PHARMACEUTICAL INDUSTRY
10.6.2 LUCRATIVE MEDICAL DEVICES INDUSTRY IN CHINA
10.6.3 GROWING NUMBER OF HOSPITALS IN ASIA
10.6.4 CONFERENCES & SYMPOSIA TO INCREASE AWARENESS
10.6.5 ENTRY OF LOCAL PLAYERS, LOW COST OF MEDICAL ANIMATION IN INDIA
10.6.6 EMERGENCE OF NEW MEDICAL INSTITUTES IN INDIA
10.7 REST OF THE WORLD (ROW)
10.7.1 FAVORABLE BUSINESS ENVIRONMENT FOR PHARMACEUTICAL AND BIOTECHNOLOGY INDUSTRIES IN SAUDI ARABIA, UAE
10.7.2 FAVORABLE ECOSYSTEM FOR MEDICAL ANIMATION IN BRAZIL
10.7.3 GOVERNMENT INITIATIVES TO ENHANCE HEALTHCARE SYSTEMS IN THE MIDDLE EAST
11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW
11.2 COMPETITIVE SITUATION AND TRENDS
11.2.1 INTRODUCTION
11.2.2 NEW PRODUCT LAUNCHES
11.2.3 MARKETING AND PROMOTIONS
11.2.4 AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS
11.2.5 EXPANSIONS
11.2.6 ACQUISITIONS
11.2.7 OTHER DEVELOPMENTS
11.3 GLOBAL MEDICAL ANIMATION MARKET: EMPIRICAL ASSESSMENT OF GROWTH STRATEGIES
11.3.1 ROUTE TO STRATEGIC GROWTH: ORGANIC AND INORGANIC GROWTH STRATEGIES
11.3.2 ORGANIC GROWTH STRATEGIES
11.3.3 INORGANIC GROWTH STRATEGIES
12 COMPANY PROFILES
(Overview, Financial*, Products & Services, Strategy, and Developments)
12.1 INFUSE MEDICAL
12.2 HYBRID MEDICAL ANIMATION, INC.
12.3 GHOST PRODUCTIONS, INC.
12.4 SCIENTIFIC ANIMATIONS, INC.
12.5 INVIVO COMMUNICATIONS, INC.
12.6 RANDOM42 SCIENTIFIC COMMUNICATION
12.7 RADIUS DIGITAL SCIENCE
12.8 NUCLEUS MEDICAL MEDIA
12.9 AXS STUDIO, INC.
12.10 VISIBLE BODY
12.11 ELARA SYSTEMS, INC.
12.12 ANIMATED BIOMEDICAL PRODUCTIONS
12.13 XVIVO SCIENTIFIC ANIMATION
12.14 BLAUSEN MEDICAL COMMUNICATIONS, INC.
12.15 UNDERSTAND.COM
12.16 TRINSIC ANIMATION, LLC.
12.17 VISCIRA
12.18 MEDMOVIE, INC.
*Details might not be captured in case of unlisted companies.
13 APPENDIX
13.1 DISCUSSION GUIDE
13.2 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
13.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.4 AVAILABLE CUSTOMIZATIONS
13.5 RELATED REPORTS
LIST OF TABLES
Table 1 NEW COMPANIES IN THE MEDICAL ANIMATION MARKET
Table 2 NUMBER OF SURGICAL PROCEDURES PERFORMED IN ENGLAND (2014)
Table 3 NUMBER OF COSMETIC SURGICAL PROCEDURES, BY COUNTRY (2014)
Table 4 NUMBER OF SURGICAL PROCEDURES PERFORMED IN INDIA
Table 5 RISING ADOPTION OF MEDICAL ANIMATION SERVICES BY PHARMACEUTICAL AND LIFE SCIENCES COMPANIES IS DRIVING THE GROWTH OF THE MEDICAL ANIMATION MARKET
Table 6 HIGH COST OF MEDICAL ANIMATION SERVICES RESTRAINING MARKET GROWTH
Table 7 LOW HEALTH LITERACY TO OFFER SIGNIFICANT GROWTH OPPORTUNITIES
Table 8 DEARTH OF CERTIFIED MEDICAL ANIMATORS IS A MAJOR CHALLENGE IN THE MEDICAL ANIMATION MARKET
Table 9 GLOBAL MEDICAL ANIMATION MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 10 3D ANIMATION MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 11 NORTH AMERICA: 3D ANIMATION MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 12 EUROPE: 3D ANIMATION MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 13 2D ANIMATION MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 14 NORTH AMERICA: 2D ANIMATION MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 15 EUROPE: 2D ANIMATION MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 16 REAL TIME IMAGING (4D ANIMATION) MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 17 NORTH AMERICA: 4D ANIMATION MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 18 EUROPE: 4D ANIMATION MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 19 FLASH ANIMATION MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 20 NORTH AMERICA: FLASH ANIMATION MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 21 EUROPE: FLASH ANIMATION MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 22 MEDICAL ANIMATION MARKET SIZE, BY THERAPEUTIC AREA, 2014–2021 (USD MILLION)
Table 23 ONCOLOGY ANIMATION MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 24 CARDIOLOGY ANIMATION MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 25 COSMECEUTICAL/PLASTIC SURGERY ANIMATION MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 26 DENTAL ANIMATION MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 27 OTHER ANIMATIONS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 28 GLOBAL MEDICAL ANIMATION MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
Table 29 MEDICAL ANIMATION MARKET SIZE FOR DRUG MOA AND APPROVAL, BY REGION, 2014–2021 (USD MILLION)
Table 30 MEDICAL ANIMATION MARKET SIZE FOR PATIENT EDUCATION, BY REGION, 2014–2021 (USD MILLION)
Table 31 MEDICAL ANIMATION MARKET SIZE FOR SURGICAL TRAINING AND PLANNING, BY REGION, 2014–2021 (USD MILLION)
Table 32 MEDICAL ANIMATION MARKET SIZE FOR CELLULAR AND MOLECULAR STUDIES, BY REGION, 2014–2021 (USD MILLION)
Table 33 OTHER MEDICAL ANIMATION APPLICATIONS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 34 GLOBAL MEDICAL ANIMATION MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 35 EFFECT OF GROWTH OF LIFE SCIENCES INDUSTRY ON MEDICAL ANIMATION MARKET
Table 36 MEDICAL ANIMATION MARKET SIZE FOR LIFE SCIENCE COMPANIES, BY REGION, 2014–2021 (USD MILLION)
Table 37 EFFECT OF GROWTH OF MEDICAL DEVICES INDUSTRY ON MEDICAL ANIMATION MARKET
Table 38 MEDICAL ANIMATION MARKET SIZE FOR MEDICAL DEVICE MANUFACTURERS, BY REGION, 2014–2021 (USD MILLION)
Table 39 EFFECT OF GROWTH HOSPITALS,SURGICAL FACILITIES, CLINICS ON MEDICAL ANIMATION MARKET
Table 40 MEDICAL ANIMATION MARKET SIZE FOR HOSPITALS, SURGICAL CENTERS, AND CLINICS, BY REGION, 2014–2021 (USD MILLION)
Table 41 MEDICAL ANIMATION MARKET SIZE FOR ACADEMIC INSTITUTES, BY REGION, 2014–2021 (USD MILLION)
Table 42 MEDICAL ANIMATION MARKET SIZE FOR OTHER END USERS, BY REGION, 2014–2021 (USD MILLION)
Table 43 MEDICAL ANIMATION MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 44 NORTH AMERICA: MEDICAL ANIMATION MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 45 NORTH AMERICA: MEDICAL ANIMATION MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 46 NORTH AMERICA: MEDICAL ANIMATION MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
Table 47 NORTH AMERICA: MEDICAL ANIMATION MARKET SIZE, BY THERAPEUTIC AREA, 2014–2021 (USD MILLION)
Table 48 NORTH AMERICA: MEDICAL ANIMATION MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 49 TOP FIVE INPATIENT SURGICAL PROCEDURES, 2014
Table 50 TOP FIVE OUTPATIENT SURGICAL PROCEDURES, 2014
Table 51 U.S.: MEDICAL ANIMATION MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 52 U.S.: MEDICAL ANIMATION MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
Table 53 U.S.: MEDICAL ANIMATION MARKET SIZE, BY THERAPEUTIC AREA, 2014–2021 (USD MILLION)
Table 54 U.S.: MEDICAL ANIMATION MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 55 CANADA: MEDICAL ANIMATION MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 56 CANADA: MEDICAL ANIMATION MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
Table 57 CANADA: MEDICAL ANIMATION MARKET SIZE, BY THERAPEUTIC AREA, 2014–2021 (USD MILLION)
Table 58 CANADA: MEDICAL ANIMATION MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 59 EUROPE: MEDICAL ANIMATION MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 60 EUROPE: MEDICAL ANIMATION MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 61 EUROPE: MEDICAL ANIMTION MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
Table 62 EUROPE: MEDICAL ANIMATION MARKET SIZE, BY THERAPEUTIC AREA, 2014–2021 (USD MILLION)
Table 63 EUROPE: MEDICAL ANIMATION MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 64 EU5: MEDICAL ANIMATION MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 65 EU5: MEDICAL ANIMATION MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
Table 66 EU5: MEDICAL ANIMATION MARKET SIZE, BY THERAPEUTIC AREA, 2014–2021 (USD MILLION)
Table 67 EU5: MEDICAL ANIMATION MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 68 ROE: MEDICAL ANIMATION MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 69 ROE: MEDICAL ANIMATION MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
Table 70 ROE: MEDICAL ANIMATION MARKET SIZE, BY THERAPEUTIC AREA, 2014–2021 (USD MILLION)
Table 71 ROE: MEDICAL ANIMATION MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 72 CONFERENCES, SYMPOSIA, & WORKSHOPS HOSTED IN ASIA-PACIFIC (2013-2016)
Table 73 ASIA-PACIFIC: MEDICAL ANIMATION MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 74 ASIA-PACIFIC: MEDICAL ANIMATION MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
Table 75 ASIA-PACIFIC: MEDICAL ANIMATION MARKET SIZE, BY THERAPEUTIC AREA, 2014–2021 (USD MILLION)
Table 76 ASIA-PACIFIC: MEDICAL ANIMATION MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 77 ROW: MEDICAL ANIMATION MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 78 ROW: MEDICAL ANIMATION MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
Table 79 ROW: MEDICAL ANIMATION MARKET SIZE, BY THERAPEUTIC AREA, 2014–2021 (USD MILLION)
Table 80 ROW: MEDICAL ANIMATION MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 81 NEW PRODUCT LAUNCHES, 2013–2016
Table 82 MARKETING AND PROMOTION, 2013–2016
Table 83 AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS, 2013–2016
Table 84 EXPANSIONS, 2013–2016
Table 85 ACQUISITIONS, 2013–2016
Table 86 OTHER DEVELOPMENTS, 2013–2016
Table 1 NEW COMPANIES IN THE MEDICAL ANIMATION MARKET
Table 2 NUMBER OF SURGICAL PROCEDURES PERFORMED IN ENGLAND (2014)
Table 3 NUMBER OF COSMETIC SURGICAL PROCEDURES, BY COUNTRY (2014)
Table 4 NUMBER OF SURGICAL PROCEDURES PERFORMED IN INDIA
Table 5 RISING ADOPTION OF MEDICAL ANIMATION SERVICES BY PHARMACEUTICAL AND LIFE SCIENCES COMPANIES IS DRIVING THE GROWTH OF THE MEDICAL ANIMATION MARKET
Table 6 HIGH COST OF MEDICAL ANIMATION SERVICES RESTRAINING MARKET GROWTH
Table 7 LOW HEALTH LITERACY TO OFFER SIGNIFICANT GROWTH OPPORTUNITIES
Table 8 DEARTH OF CERTIFIED MEDICAL ANIMATORS IS A MAJOR CHALLENGE IN THE MEDICAL ANIMATION MARKET
Table 9 GLOBAL MEDICAL ANIMATION MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 10 3D ANIMATION MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 11 NORTH AMERICA: 3D ANIMATION MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 12 EUROPE: 3D ANIMATION MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 13 2D ANIMATION MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 14 NORTH AMERICA: 2D ANIMATION MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 15 EUROPE: 2D ANIMATION MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 16 REAL TIME IMAGING (4D ANIMATION) MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 17 NORTH AMERICA: 4D ANIMATION MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 18 EUROPE: 4D ANIMATION MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 19 FLASH ANIMATION MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 20 NORTH AMERICA: FLASH ANIMATION MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 21 EUROPE: FLASH ANIMATION MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 22 MEDICAL ANIMATION MARKET SIZE, BY THERAPEUTIC AREA, 2014–2021 (USD MILLION)
Table 23 ONCOLOGY ANIMATION MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 24 CARDIOLOGY ANIMATION MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 25 COSMECEUTICAL/PLASTIC SURGERY ANIMATION MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 26 DENTAL ANIMATION MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 27 OTHER ANIMATIONS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 28 GLOBAL MEDICAL ANIMATION MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
Table 29 MEDICAL ANIMATION MARKET SIZE FOR DRUG MOA AND APPROVAL, BY REGION, 2014–2021 (USD MILLION)
Table 30 MEDICAL ANIMATION MARKET SIZE FOR PATIENT EDUCATION, BY REGION, 2014–2021 (USD MILLION)
Table 31 MEDICAL ANIMATION MARKET SIZE FOR SURGICAL TRAINING AND PLANNING, BY REGION, 2014–2021 (USD MILLION)
Table 32 MEDICAL ANIMATION MARKET SIZE FOR CELLULAR AND MOLECULAR STUDIES, BY REGION, 2014–2021 (USD MILLION)
Table 33 OTHER MEDICAL ANIMATION APPLICATIONS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 34 GLOBAL MEDICAL ANIMATION MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 35 EFFECT OF GROWTH OF LIFE SCIENCES INDUSTRY ON MEDICAL ANIMATION MARKET
Table 36 MEDICAL ANIMATION MARKET SIZE FOR LIFE SCIENCE COMPANIES, BY REGION, 2014–2021 (USD MILLION)
Table 37 EFFECT OF GROWTH OF MEDICAL DEVICES INDUSTRY ON MEDICAL ANIMATION MARKET
Table 38 MEDICAL ANIMATION MARKET SIZE FOR MEDICAL DEVICE MANUFACTURERS, BY REGION, 2014–2021 (USD MILLION)
Table 39 EFFECT OF GROWTH HOSPITALS,SURGICAL FACILITIES, CLINICS ON MEDICAL ANIMATION MARKET
Table 40 MEDICAL ANIMATION MARKET SIZE FOR HOSPITALS, SURGICAL CENTERS, AND CLINICS, BY REGION, 2014–2021 (USD MILLION)
Table 41 MEDICAL ANIMATION MARKET SIZE FOR ACADEMIC INSTITUTES, BY REGION, 2014–2021 (USD MILLION)
Table 42 MEDICAL ANIMATION MARKET SIZE FOR OTHER END USERS, BY REGION, 2014–2021 (USD MILLION)
Table 43 MEDICAL ANIMATION MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 44 NORTH AMERICA: MEDICAL ANIMATION MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 45 NORTH AMERICA: MEDICAL ANIMATION MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 46 NORTH AMERICA: MEDICAL ANIMATION MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
Table 47 NORTH AMERICA: MEDICAL ANIMATION MARKET SIZE, BY THERAPEUTIC AREA, 2014–2021 (USD MILLION)
Table 48 NORTH AMERICA: MEDICAL ANIMATION MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 49 TOP FIVE INPATIENT SURGICAL PROCEDURES, 2014
Table 50 TOP FIVE OUTPATIENT SURGICAL PROCEDURES, 2014
Table 51 U.S.: MEDICAL ANIMATION MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 52 U.S.: MEDICAL ANIMATION MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
Table 53 U.S.: MEDICAL ANIMATION MARKET SIZE, BY THERAPEUTIC AREA, 2014–2021 (USD MILLION)
Table 54 U.S.: MEDICAL ANIMATION MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 55 CANADA: MEDICAL ANIMATION MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 56 CANADA: MEDICAL ANIMATION MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
Table 57 CANADA: MEDICAL ANIMATION MARKET SIZE, BY THERAPEUTIC AREA, 2014–2021 (USD MILLION)
Table 58 CANADA: MEDICAL ANIMATION MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 59 EUROPE: MEDICAL ANIMATION MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 60 EUROPE: MEDICAL ANIMATION MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 61 EUROPE: MEDICAL ANIMTION MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
Table 62 EUROPE: MEDICAL ANIMATION MARKET SIZE, BY THERAPEUTIC AREA, 2014–2021 (USD MILLION)
Table 63 EUROPE: MEDICAL ANIMATION MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 64 EU5: MEDICAL ANIMATION MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 65 EU5: MEDICAL ANIMATION MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
Table 66 EU5: MEDICAL ANIMATION MARKET SIZE, BY THERAPEUTIC AREA, 2014–2021 (USD MILLION)
Table 67 EU5: MEDICAL ANIMATION MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 68 ROE: MEDICAL ANIMATION MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 69 ROE: MEDICAL ANIMATION MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
Table 70 ROE: MEDICAL ANIMATION MARKET SIZE, BY THERAPEUTIC AREA, 2014–2021 (USD MILLION)
Table 71 ROE: MEDICAL ANIMATION MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 72 CONFERENCES, SYMPOSIA, & WORKSHOPS HOSTED IN ASIA-PACIFIC (2013-2016)
Table 73 ASIA-PACIFIC: MEDICAL ANIMATION MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 74 ASIA-PACIFIC: MEDICAL ANIMATION MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
Table 75 ASIA-PACIFIC: MEDICAL ANIMATION MARKET SIZE, BY THERAPEUTIC AREA, 2014–2021 (USD MILLION)
Table 76 ASIA-PACIFIC: MEDICAL ANIMATION MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 77 ROW: MEDICAL ANIMATION MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 78 ROW: MEDICAL ANIMATION MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
Table 79 ROW: MEDICAL ANIMATION MARKET SIZE, BY THERAPEUTIC AREA, 2014–2021 (USD MILLION)
Table 80 ROW: MEDICAL ANIMATION MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 81 NEW PRODUCT LAUNCHES, 2013–2016
Table 82 MARKETING AND PROMOTION, 2013–2016
Table 83 AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS, 2013–2016
Table 84 EXPANSIONS, 2013–2016
Table 85 ACQUISITIONS, 2013–2016
Table 86 OTHER DEVELOPMENTS, 2013–2016
LIST OF FIGURES
Figure 1 GLOBAL MEDICAL ANIMATION MARKET: RESEARCH METHODOLOGY STEPS
Figure 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
Figure 3 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
Figure 4 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
Figure 5 RESEARCH DESIGN: MEDICAL ANIMATION MARKET
Figure 6 DATA TRIANGULATION METHODOLOGY
Figure 7 REAL TIME IMAGING (4D ANIMATION) SEGMENT TO WITNESS THE HIGHEST GROWTH RATE FROM 2016 TO 2021
Figure 8 PATIENT EDUCATION SEGMENT TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD
Figure 9 COSMECEUTICALS/PLASTIC SURGERY SEGMENT TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD
Figure 10 LIFE SCIENCES COMPANIES SEGMENT WILL CONTINUE TO DOMINATE THE MEDICAL ANIMATION MARKET IN 2021
Figure 11 ASIA-PACIFIC REGION TO WITNESS THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD
Figure 12 RISING ADOPTION OF MEDICAL ANIMATION BY LIFE SCIENCES & MEDICAL DEVICE COMPANIES—A KEY DRIVER PROPELLING MARKET GROWTH FROM 2016 TO 2021
Figure 13 DRUG MOA AND APPROVAL TO DOMINATE THE MARKET IN 2016
Figure 14 NORTH AMERICA DOMINATES THE MEDICAL ANIMATION MARKET IN 2016
Figure 15 LIFE SCIENCES COMPANIES SEGMENT TO WITNESS THE HIGHEST GROWTH RATE IN THE FORECAST PERIOD
Figure 16 ASIA-PACIFIC REGION TO GROW AT THE HIGHEST CAGR FROM 2016 TO 2021
Figure 17 MEDICAL ANIMATION MARKET: SEGMENTATION
Figure 18 MEDICAL ANIMATION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, & CHALLENGES
Figure 19 SMARTPHONE CONNECTIONS (MILLIONS) AND ADOPTION RATE WORLDWIDE, 2008 TO 2020
Figure 20 MEDICAL ANIMATION MARKET, BY TYPE
Figure 21 3D ANIMATION TO ACCOUNT FOR THE LARGEST SHARE OF MEDICAL ANIMATION MARKET IN 2016
Figure 22 MEDICAL ANIMATION MARKET SEGMENTATION, BY THERAPEUTIC AREA
Figure 23 COSMECEUTICALS/PLASTIC SURGERY SEGMENT TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD
Figure 24 MEDICAL ANIMATION MARKET SEGMENTATION, BY APPLICATION
Figure 25 DRUG MOA & APPROVAL SEGMENT TO ACCOUNT FOR THE LARGEST SHARE OF MEDICAL ANIMATION MARKET
Figure 26 MEDICAL ANIMATION MARKET SEGMENTATION, BY END USER
Figure 27 LIFE SCIENCE COMPANIES TO ACCOUNT FOR THE LARGEST SHARE OF THE MEDICAL ANIMATION END-USER MARKET IN 2016
Figure 28 NORTH AMERICA TO COMMAND THE LARGEST MARKET SIZE OF THE GLOBAL MEDICAL ANIMATION MARKET IN 2016
Figure 29 NORTH AMERICA: MEDICAL ANIMATION MARKET SNAPSHOT
Figure 30 EUROPE: MEDICAL ANIMATION MARKET SNAPSHOT
Figure 31 ASIA-PACIFIC: MEDICAL ANIMATION MARKET SNAPSHOT
Figure 32 ROW: MEDICAL ANIMATION MARKET SNAPSHOT
Figure 33 TOP 5 STRATEGIES ADOPTED BY PLAYERS OVER THE LAST THREE YEARS (2013-2016)
Figure 34 BATTLE FOR MARKET SHARE: NEW PRODUCT LAUNCHES WAS THE KEY STRATEGY ADOPTED BY MARKET PLAYERS (2013–2016)
Figure 35 ORGANIC & INORGANIC GROWTH STRATEGIES: INDUSTRY TREND VS. KEY PLAYERS
Figure 36 ORGANIC GROWTH STRATEGIES, BY KEY PLAYER (2013–2016)
Figure 37 INORGANIC GROWTH STRATEGIES, BY KEY PLAYER (2013–2016)
Figure 1 GLOBAL MEDICAL ANIMATION MARKET: RESEARCH METHODOLOGY STEPS
Figure 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
Figure 3 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
Figure 4 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
Figure 5 RESEARCH DESIGN: MEDICAL ANIMATION MARKET
Figure 6 DATA TRIANGULATION METHODOLOGY
Figure 7 REAL TIME IMAGING (4D ANIMATION) SEGMENT TO WITNESS THE HIGHEST GROWTH RATE FROM 2016 TO 2021
Figure 8 PATIENT EDUCATION SEGMENT TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD
Figure 9 COSMECEUTICALS/PLASTIC SURGERY SEGMENT TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD
Figure 10 LIFE SCIENCES COMPANIES SEGMENT WILL CONTINUE TO DOMINATE THE MEDICAL ANIMATION MARKET IN 2021
Figure 11 ASIA-PACIFIC REGION TO WITNESS THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD
Figure 12 RISING ADOPTION OF MEDICAL ANIMATION BY LIFE SCIENCES & MEDICAL DEVICE COMPANIES—A KEY DRIVER PROPELLING MARKET GROWTH FROM 2016 TO 2021
Figure 13 DRUG MOA AND APPROVAL TO DOMINATE THE MARKET IN 2016
Figure 14 NORTH AMERICA DOMINATES THE MEDICAL ANIMATION MARKET IN 2016
Figure 15 LIFE SCIENCES COMPANIES SEGMENT TO WITNESS THE HIGHEST GROWTH RATE IN THE FORECAST PERIOD
Figure 16 ASIA-PACIFIC REGION TO GROW AT THE HIGHEST CAGR FROM 2016 TO 2021
Figure 17 MEDICAL ANIMATION MARKET: SEGMENTATION
Figure 18 MEDICAL ANIMATION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, & CHALLENGES
Figure 19 SMARTPHONE CONNECTIONS (MILLIONS) AND ADOPTION RATE WORLDWIDE, 2008 TO 2020
Figure 20 MEDICAL ANIMATION MARKET, BY TYPE
Figure 21 3D ANIMATION TO ACCOUNT FOR THE LARGEST SHARE OF MEDICAL ANIMATION MARKET IN 2016
Figure 22 MEDICAL ANIMATION MARKET SEGMENTATION, BY THERAPEUTIC AREA
Figure 23 COSMECEUTICALS/PLASTIC SURGERY SEGMENT TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD
Figure 24 MEDICAL ANIMATION MARKET SEGMENTATION, BY APPLICATION
Figure 25 DRUG MOA & APPROVAL SEGMENT TO ACCOUNT FOR THE LARGEST SHARE OF MEDICAL ANIMATION MARKET
Figure 26 MEDICAL ANIMATION MARKET SEGMENTATION, BY END USER
Figure 27 LIFE SCIENCE COMPANIES TO ACCOUNT FOR THE LARGEST SHARE OF THE MEDICAL ANIMATION END-USER MARKET IN 2016
Figure 28 NORTH AMERICA TO COMMAND THE LARGEST MARKET SIZE OF THE GLOBAL MEDICAL ANIMATION MARKET IN 2016
Figure 29 NORTH AMERICA: MEDICAL ANIMATION MARKET SNAPSHOT
Figure 30 EUROPE: MEDICAL ANIMATION MARKET SNAPSHOT
Figure 31 ASIA-PACIFIC: MEDICAL ANIMATION MARKET SNAPSHOT
Figure 32 ROW: MEDICAL ANIMATION MARKET SNAPSHOT
Figure 33 TOP 5 STRATEGIES ADOPTED BY PLAYERS OVER THE LAST THREE YEARS (2013-2016)
Figure 34 BATTLE FOR MARKET SHARE: NEW PRODUCT LAUNCHES WAS THE KEY STRATEGY ADOPTED BY MARKET PLAYERS (2013–2016)
Figure 35 ORGANIC & INORGANIC GROWTH STRATEGIES: INDUSTRY TREND VS. KEY PLAYERS
Figure 36 ORGANIC GROWTH STRATEGIES, BY KEY PLAYER (2013–2016)
Figure 37 INORGANIC GROWTH STRATEGIES, BY KEY PLAYER (2013–2016)
